Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid plus vancomycin paste to reduce bleeding after CABG
IRCT20190714044205N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid and vancomycin in postoperative hemorrhage (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Volume of bleeding and Volume of injected blood products. Started Jun 2019; status: completed.
02
Drugs
tranexamic acidvancomycin
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on IRCT20190714044205N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190714044205N1.